NEW YORK (GenomeWeb) – OpGen has raised about $1.1 million toward a targeted $1.5 million financing round, the firm disclosed in a regulatory document recently.

A spokesperson for the Gaithersburg, Md.-based microbial genetics analysis firm said that the initial funds are part of a Series B financing round that OpGen expects to close in the fall. It will use the money to commercialize the Acuitas MDRO Gene Test, a molecular test for identifying patients at risk of harboring antibiotic-resistant disease-causing microbes.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.